Demonstrating the Value of Specialty Inflammatory Medications
Inflammatory medications are one of the top drivers of specialty drug spend. While these costly drugs can provide relief for members, there are also many hurdles that can lead to medication non-adherence, causing waste and less than optimal outcomes for members. In this first of a series of video blogs, Marly Arbuckle, senior director, specialty solutions and strategy explores the key performance indicators that should be monitored to minimize waste and help members achieve whole health for life.
Key performance indicators that should be monitored for other specialty medications. Download our KPI Report.